Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype-Specific Pneumonia.

Clin Infect Dis

Bill and Melinda Gates Foundation, Seattle, Washington, USA.

Published: October 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492200PMC
http://dx.doi.org/10.1093/cid/ciaa1867DOI Listing

Publication Analysis

Top Keywords

impact pneumococcal
4
pneumococcal conjugate
4
conjugate vaccine
4
vaccine vaccine
4
vaccine serotype-specific
4
serotype-specific pneumonia
4
vaccine
2
impact
1
conjugate
1
serotype-specific
1

Similar Publications

Haematopoietic stem cell transplantation (HCT) induces profound immunosuppression, significantly increasing susceptibility to severe infections. This review examines vaccinations' necessity, timing, and efficacy post-HCT to reduce infection-related morbidity and mortality. It aims to provide a structured protocol aligned with international and national recommendations.

View Article and Find Full Text PDF

Heart failure (HF) affects 64 million people worldwide and is one of the most prevalent causes of hospitalization in adults. Infection is believed to be one of the potential triggers that may facilitate HF decompensation and the need for hospitalization. Therefore, it seems crucial to safeguard against such a situation.

View Article and Find Full Text PDF

Pneumonia is the second leading cause of hospital admissions and deaths among children <5 years in Uganda. In 2014, Uganda officially rolled out the introduction of the pneumococcal conjugate vaccine (PCV) into routine immunization schedule. However, little is known about the long-term impact of PCV on pneumonia admissions and deaths.

View Article and Find Full Text PDF

Background: Serotype-specific urinary antigen detection (UAD) assay results can be used to estimate the serotype contribution among adults with pneumococcal community-acquired pneumonia (CAP) and to guide recommendations regarding higher-valency pneumococcal conjugate vaccines (PCVs).

Methods: Adults aged ≥18 years hospitalized with radiographic evidence of CAP were prospectively enrolled in 4 US cities from November 2019 to December 2020, overlapping the coronavirus disease 2019 (COVID-19) pandemic. Data were collected by patient interview and medical chart review.

View Article and Find Full Text PDF

Objective: To better understand the protective benefit of pneumococcal vaccines on rates of meningitis after cochlear implantation.

Study Design: Retrospective large database review.

Setting: Several studies have shown that cochlear implantation increases the incidence of bacterial meningitis, mostly due to pneumococcal meningitis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!